Immobilization Stress With α2-Adrenergic Stimulation Induces Regional and Transient Reduction of Cardiac Contraction Through Gi Coupling in Rats

International Heart Journal
Ryohei KurodaKen-Ichi Yoshida

Abstract

Stress cardiomyopathy is characterized by transient apical hypokinesia related to catecholamine overflow. Recently, excessive epinephrine administration was shown to recapitulate stress cardiomyopathy through β2-adrenoceptor (AR)-inhibitory G protein (Gi) coupling in rats. We aimed to study whether α2-AR and Gi affect cardiac contraction in rats in which emotional stress was evoked using immobilization (IMO). Echocardiography results showed that when male rats were exposed to IMO for 30 minutes and then injected with the α2-AR agonist xylazine (Xy), ejection fraction and the movement of the anterior wall (AW) were suppressed, maximally at 5 minutes post-injection, whereas posterior wall (PW) movement was preserved. At the same time points, the phosphorylation of Ser282 in myosin-binding protein-C (MyBP-C-Ser282) was higher in the PW than in the AW. Pretreatment with the Gi inhibitor pertussis toxin (PTX) reversed the low contractility and MyBP-C-Ser282 phosphorylation in the AW, but induced lethal heart failure in 3 out of 11 rats. Moreover, at 5 minutes after Xy injection following 30 minutes of IMO, serum epinephrine levels were increased. Thus, in rats exposed to psychological stress, α2-AR stimulation triggered transient hy...Continue Reading

References

Mar 1, 1979·The American Journal of Physiology·R KvetnanskyI J Kopin
Apr 1, 1987·Canadian Journal of Physiology and Pharmacology·S FoucartJ de Champlain
Apr 1, 1971·Circulation·J F PomboR O Russell
Mar 1, 1995·Basic Research in Cardiology·R J GryglewskiP Niezabitowski
Jun 3, 1998·The Journal of Neuropsychiatry and Clinical Neurosciences·H Selye
Dec 16, 1998·European Journal of Pharmacology·J R Docherty
Oct 23, 2001·American Journal of Physiology. Heart and Circulatory Physiology·H Mukundan, N L Kanagy
Mar 20, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Tsuyoshi AkiyamaKenji Sunagawa
May 18, 2004·Journal of Applied Physiology·Mahmoud M El-Mas, Abdel A Abdel-Rahman
Jul 9, 2004·Annals of the New York Academy of Sciences·Jaromír MyslivecekRichard Kvetnanský
Oct 18, 2005·Cardiovascular Research·Alicia MattiazziEvangelia Kranias
Mar 2, 2006·European Journal of Anaesthesiology·R Aantaa, J Jalonen
Mar 17, 2007·Circulation Research·Rajkumar MantravadiGuy Salama
Dec 21, 2007·Nature Clinical Practice. Cardiovascular Medicine·Alexander R LyonSian E Harding
Dec 25, 2008·Circulation·Yoshihiro J AkashiTakashi Ueyama
Jul 28, 2009·American Journal of Physiology. Heart and Circulatory Physiology·ByungSu YooHoward A Rockman
Aug 19, 2009·Annual Review of Medicine·Yoshihiro J AkashiTakashi Ueyama
Nov 4, 2009·Journal of Molecular and Cellular Cardiology·Michael Grimm, Joan Heller Brown
Dec 8, 2009·Journal of Molecular and Cellular Cardiology·David Barefield, Sakthivel Sadayappan
Feb 13, 2010·The Heart Surgery Forum·João Bosco DupinOtoni M Gomes
Apr 10, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Kana UnumaKen-ichi Yoshida
Oct 23, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Kana UnumaKen-ichi Yoshida
Jan 25, 2011·The Journal of Biological Chemistry·Jeanne James, Jeffrey Robbins
Dec 20, 2011·Circulation Research·Weizhong ZhuRui-Ping Xiao
Jul 9, 2013·European Heart Journal Cardiovascular Imaging·Bjorn RedforsElmir Omerovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.